BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2573371)

  • 1. Redistribution of cardiac output to the kidneys by tertatolol does not involve prostaglandins.
    Naeije R; Degaute JP
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):241S-244S. PubMed ID: 2573371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserved renal perfusion during beta blockade by tertatolol with and without cyclooxygenase inhibition in normal humans.
    Reuse C; Leeman M; Degaute JP; Abramowicz M; Prost JF; Naeije R
    J Clin Pharmacol; 1988 Apr; 28(4):312-6. PubMed ID: 3134468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of tertatolol and nadolol on systemic and renal hemodynamics in patients with essential hypertension.
    Degaute JP; Naeije R; Abramowicz M; Leeman M; Schoutens A; Prost JF
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):263S-268S. PubMed ID: 3415803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tertatolol on glomerular hemodynamics in the normal Munich-Wistar rat.
    Gabbai FB; Peterson OW; Prost JF; Blantz RC
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):213S-218S. PubMed ID: 2573366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal effects of intravenous tertatolol in essential arterial hypertension].
    Chaignon M; Brouard R; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F; Lantz B; Leviel F; Ardaillou R
    Am J Nephrol; 1986; 6 Suppl 2():40-4. PubMed ID: 2879472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tertatolol on renal function in the isolated perfused rat kidney.
    Perico N; Remuzzi G
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):223S-227S. PubMed ID: 2573368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertatolol preserves renal perfusion in patients with arterial hypertension after head injury.
    Leeman M; Naeije R; Degaute JP; Brackman F; Thomas J; Prost JF
    Am J Nephrol; 1986; 6 Suppl 2():36-9. PubMed ID: 2879471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute central and renal haemodynamic responses to tertatolol and propranolol in patients with arterial hypertension following head injury.
    Leeman M; Naeije R; Degaute JP; Brackman F; Prost JF
    J Hypertens; 1986 Oct; 4(5):581-7. PubMed ID: 2878953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in renal hemodynamics during chronic and acute beta-blockade in humans.
    Beaufils M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):233S-236S. PubMed ID: 2573369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal hemodynamic effects of tertatolol compared with those of propranolol in the conscious dog.
    Laubie M; Prost JF; Rochat C
    Am J Nephrol; 1986; 6 Suppl 2():20-4. PubMed ID: 2879468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tertatolol in hypertensive patients with chronic renal failure.
    Beaufils M; Lantz B; Paillard F; Richet G
    Am J Nephrol; 1986; 6 Suppl 2():50-4. PubMed ID: 2879474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta blockers induce different intrarenal effects in humans: demonstration by selective infusion of tertatolol and propranolol.
    Nitenberg A; Chemla D; Blanchet F; Guery O; Prost JF; Dutray-Dupagne C
    J Clin Pharmacol; 1990 Oct; 30(10):930-7. PubMed ID: 1977772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecificity of beta-adrenoceptor blockade and renal vasodilatation by tertatolol.
    Smits JF; Zeegers HH; Struyker-Boudier HA
    Arch Int Pharmacodyn Ther; 1989; 298():164-71. PubMed ID: 2569294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological features of the vasodilation induced by tertatolol in isolated perfused rat kidneys.
    Verbeuren TJ; Herman AG
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):219S-222S. PubMed ID: 2573367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
    Plante GE; Prévost C; Sirois P; Rochat C; Prost JF
    J Pharmacol Exp Ther; 1989 Feb; 248(2):741-6. PubMed ID: 2563770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
    Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure.
    Hannedouche T; Brouard R; Godin M; Kleinknecht D; Paillard F; Grünfeld JP
    Nephrol Dial Transplant; 1991; 6(4):252-6. PubMed ID: 1679214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tertatolol, a beta-adrenoceptor antagonist with agonist affinity at 5-HT1A receptors, in an animal model of migraine: comparison with propranolol and pindolol.
    Saxena PR; Heiligers JP; Villalón CM; Ferrari MD
    Eur J Pharmacol; 1992 Sep; 220(1):79-86. PubMed ID: 1358648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.